We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Membrane Protein Structure Visualized Using Emerging X-Ray Technology despite Existing Damage

By LabMedica International staff writers
Posted on 23 Jan 2011
Print article
Australian researchers have found a way to measure the structure of membrane proteins in spite of being damaged when using X-ray free-electron lasers (XFELs), a discovery that will help fast track the development of targeted drugs using new XFELs technology.

Approximately 70% of drugs on the market today depend on the activity of membrane proteins, which are complex molecules that form the membranes of the cells in our body. A major problem for the design of new pharmaceuticals, often known as the "membrane protein problem,” is that they do not form the crystals needed to enable further investigation of the structure to design better drugs.

A large international effort is being undertaken to determine the structures of membrane proteins using XFELs--large facilities that create such a bright beam of X-rays it is possible to see the X-ray light bouncing off a single molecule without forming a crystal.

Prof. Keith Nugent, and ARC Federation fellow and director of the Australian Research Council Center of Excellence for Coherent X-ray Science (CXS) at the University of Melbourne (Australia) reported that a key problem was that the light from an XFEL was so bright a molecule would start to disintegrate in less than one thousandth of a millionth of a millionth of a second.

In an article published online December 19, 2010, in the journal Nature Physics, Prof. Nugent and Associate Prof. Harry Quiney from the ARC Center of Excellence for Coherent X-ray Science (CXS) have developed a method by which the damage from the XFEL pulse may be included in the data analysis. Associate Prof. Quiney, also from the School of Physics at the University of Melbourne, reported that the study's findings revealed that high-resolution molecular structures may be obtained from X-ray scattering data using a few-femtosecond pulse from an XFEL, even if the interaction resulted in significant electronic damage to the target. "This result has far-reaching implications for the future development of structural biology, because it removes a significant obstacle to the practical realization of the molecular microscope using XFEL sources,” he said.

The technology also provides significant clues into the complex, raging, and little-understood interactions that are driven by the interaction of an XFEL pulse with an atom, molecule, or solid. The scientists' approach uses advanced molecular physics and precise data analysis to determine a new approach to measuring molecular structure. Although still at the theoretic and computation level when put into practice, this finding should remove a major hurdle in the path to solving the membrane protein problem.

In 2010, CXS signed an agreement with Japanese colleagues and will host the 4th Asia-Oceania Workshop on Science with X-ray Free Electron Lasers in 2011.

Prof. Nugent noted that this was an extremely exciting time for X-ray science. "My colleagues and I are convinced that our recent work is a critically important step forward,” he said. "We are very much looking forward to working with our Japanese colleagues in the coming years.”

The first XFEL began operating at Stanford University in Palo Alto, CA, USA, in 2009 and the second, the SPring8 facility in Harima Science Park City, Hyogo Prefecture, Japan, will start in 2011. A third is under construction in Europe to commence in 2014.

Related Links:
University of Melbourne


Gold Member
Hematology Analyzer
Swelab Lumi
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Thyroid ELISA Kit
AESKULISA a-TPO
New
Food Allergens Assay Kit
Allerquant 14G A

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.